The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: A staged prognostic model
Abstract
OBJECTIVE: Current prognostic models in primary biliary cirrhosis (PBC) have low precision, partly due to the restricted inclusion criteria of some cohorts used for modelling but also because of the prolonged natural course of the disease. It is hypothesized that better precision could be achieved with a staged model, using ascites or peripheral oedema as a new starting-point for prediction. MATERIAL AND METHODS: The study was based on an established database of 289 consecutive patients, followed between 1977 and 1998. Stepwise Cox regression was used to construct a staged model based on 143 patients who first developed ascites (n=111) or peripheral oedema (n=32) at entry or during subsequent follow-up. The model was compared with published models using graphical methods and receiver operating characteristics (ROCs). RESULTS: Mean time from clinical diagnosis of ascites or peripheral oedema to death was 3.1 years. The following variables had independent prognostic significance: log10(bilirubin) (p<0.001), albumin (p<0.001), age (p<0.001) and history of encephalopathy (p<0.001). Goodness of fit showed that the survival probabilities predicted by the Ascites Stage Model fitted well with the observed data. The Ascites Stage Model (ROC 0.8324 (SE 0.0348)) was a better predictor of survival than the Mayo long-term model (ROC 0.7833 (SE 0.0397)), the Mayo Repeated Patient Visits Model (ROC 0.7779 (SE 0.0399)) and the Royal Free PBC Prognostic Model (ROC 0.7785 (SE 0.0396)). CONCLUSIONS: The Ascites Stage Model gives a better survival estimate for PBC patients once they have developed ascites or peripheral oedema compared with the current models, and demonstrates an advantage of staged models in diseases with a prolonged natural history.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 143 patients who first developed ascites or peripheral oedema, the mean time to death was 3.1 years.131”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [131]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 1×
“The assumption of proportional hazards was tested using the procedure ‘‘stphtest’’ in STATA, which is based on a test proposed by Grambsch & Therneau [13].”
MethodKaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 2,016
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816 · cited 16×
“0396)) or the Mayo Long-Term Survival Model [6] (ROC 0.”
BackgroundMethodInfluentialKaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 459
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
Christensen, E., Neuberger, J., Crowe, J., Altman, D. G., Pópper, H., Portmann, B. C., Doniach, D., Ranek, L., Tygstrup, N., & Williams, R. L. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90213-6 · Cited by 420
Roll, J., Boyer, J. L., Barry, D., & Klatskin, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080101 · Cited by 417
Goulis, J., Leandro, G., & Burroughs, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11293-x · Cited by 315
Self-citationUrsodeoxycholic acid for primary biliary cirrhosis
Rudić, J. S., Poropat, G., Krstic, M. N., Bjelaković, G., & Gluud, C. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000551.pub3 · Cited by 277
Research works printed but not linked: 4
- Gluud C, The Cochrane Library
- Salerno F, 1993, Am J Gastroenterol, 88, 514
- Cleves M, 1999, Stata Tech Bull, 52, sg120
- Goudie BM, 1989, Am J Gastroenterol, 84, 713
Cited by
Sorted by citations
Portal Hypertension and Its Complications
Sanyal, A. J., Bosch, J., Blei, A. T., & Arroyo, V. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.007 · Cited by 360
Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Hirschfield, G. M., & Heathcote, E. J. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch32 · Cited by 261
Ageing, telomeres, senescence, and liver injury
Hoare, M., Das, T., & Alexander, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.009 · Cited by 184
Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K. D., Floreani, A., et al. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.440 · Cited by 98
Natural History of Primary Biliary Cirrhosis
Mayo, M. J. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.012 · Cited by 45
Diagnosis and treatment of primary biliary cholangitis
Laschtowitz, A., de Veer, R. C., der Meer, A. J. V., & Schramm, C. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620919585 · Cited by 38
Papastergiou, V., Tsochatzis, E. A., Rodríguez‐Perálvarez, M., Thalassinos, E., Pieri, G., Manousou, P., Germani, G., Rigamonti, C., Arvaniti, V., Karatapanis, S., et al. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12522 · Cited by 35
Self-citationImproving prognosis in primary biliary cholangitis – Therapeutic options and strategy
Harms, M. H., van Buuren, H. R., & van der Meer, A. J. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.06.004 · Cited by 14
Tsochatzis, E. A., Feudjo, M., Rigamonti, C., Vlachogiannakos, J., Carpenter, J. R., & Burroughs, A. K. (2013) · BioMed Research International · doi:10.1155/2013/139763 · Cited by 8
Self-citationLindor, K. D., & Levy, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00041-3 · Cited by 8
Chan, C.-W., Tsochatzis, E., Carpenter, J., Rigamonti, C., Gunsar, F., & Burroughs, A. (2010) · Alimentary Pharmacology and Therapeutics · doi:10.1111/j.1365-2036.2009.04215.x · Cited by 8
Self-citationAzemoto, N., Abe, M., Murata, Y., Murakami, H., Matsuura, B., Hiasa, Y., & Onji, M. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3169 · Cited by 2
Sclair, S. N., & Levy, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00042-2 · Cited by 2
Carey, E. J., & Levy, C. (2018) · Clinics in Liver Disease · doi:10.1016/s1089-3261(18)30044-8
ortal Hypertension and Its Complications
Sanyal, A. J., Bosch, J., Blei, A. T., & Arroyo, V. (2008)
Improving Non-IID federated survival analysis with data augmentation and gradient boosted trees
Zhang, X., Zou, Y., Huang, Y., Ng, S., & Wang, H. (2026) · Applied Intelligence · doi:10.1007/s10489-026-07147-8
Metadata
- Authors
- Chan, C.-W., Carpenter, J. R., Rigamonti, C., Gunsar, F., & Burroughs, A. K.
- Affiliations
- The Royal Free Hospital (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Royal Free London NHS Foundation Trust (GB)
- Corresponding author
- Burroughs, Andrew K.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 40
- Issue
- 9
- Pages
- 1081-1089
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W2148674881
- Cited by
- 17
- References
- 21
- Citations by year
- 2026: 1 · 2020: 1 · 2018: 4 · 2017: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Economic and Social Research Council
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary biliary cirrhosis, ascites, peripheral edema, survival prediction, prognostic model, bilirubin, serum albumin, encephalopathy
- MeSH terms
- Ascites, Edema, Female, Follow-Up Studies, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Prognosis, Retrospective Studies, Severity of Illness Index, Time Factors, Survival Rate, Proportional Hazards Models, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
